The FDA and the US Customs and Border Protection (CBP) have agreed to join forces and "maximize inspection and detection capabilities" in deterring the illegal entry of unapproved fentanyl products, counterfeit prescriptions and over-the-counter drugs at the border.
As part of the agreement, signed on April 4, participants plan to establish an expanded scientific presence at International...